Published Date : Aug 01, 2016
Albany, NY, Aug 01, 2016: Immunotherapy, commonly termed as desensitization, is used to cure many allergic disorders, including allergic asthma and allergic rhinitis. Allergies usually occur when a foreign particle reacts with the body’s immune system, producing an unnaturally intense reaction. Dust mites, mold, and animal dander are some of the common allergens. Asthma, rashes, rhinitis, and ocular problems such as scratchy and red eyes are some of the commonly found manifestations of allergies. A few allergies can be easily treated, while many others are difficult to treat as they carry severe effects. The growing occurrence of allergies is expected to propel the global allergy immunotherapies market in the coming years, predicts a new report added to the repository of MarketResearchReports.biz.
The report defines allergy immunotherapy and diverts its focus towards studying the recent advancements in immunotherapies. After listing the leading players in the global market, the study then focuses on the changing trends in the market. As per the findings of the report, the global allergy immunotherapies market is expected to expand at a rapid pace in the years to come due to factors such as advancements in medical devices, availability of enhanced healthcare infrastructure, and the growing adoption of technologically sound surgical and therapeutic tools.
The publication, titled ‘Global Allergy Immunotherapies Market 2016-2020,’ states that the market is expected to exhibit a steady CAGR of 7.30% during the period between 2016 and 2020. The market is expected to be challenged by high dropout rates and poor patient adherence, state the report’s authors. However, factors such as the presence of high unmet medical needs, and the advent of SPIRE are predicted to propel the global allergy immunotherapies market.
For a detailed study, the analysts have segmented the global allergy immunotherapies market on the basis of region and product type. Based on product type, the global market for allergy immunotherapies is classified into SCIT, SLITT, and SLITD.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/746007
Based on region, the global allergy immunotherapies market is divided into Europe, North America, and Rest of the World. The rising occurrence of allergies caused by outdoor allergens and the increasing occurrence of allergic rhinitis are predicted to create new growth opportunities in the global allergy immunotherapies market. The report studies companies such as ALK-Abello, Stallergenes, Merck Group, Allergy Therapeutics, Adamis Pharmaceuticals, Aimmune Therapeutics, Anergis, ASIT biotech, Biomay, Circassia, DBV Technologies, Genentech, HAL Allergy, Laboratorios LETI, and Mitsubishi Tanabe Pharma for a competitive reports.
The study measures the changing trends in the global market for allergy immunotherapies. As per the research done by the analysts, the rise in environmental pollution in recent years is expected to increase the prevalence of skin and eye allergies. This is expected to propel the global market in the long run. The increasing number of immunotherapies in the pipeline and high consumption of tobacco are also predicted to boost the global allergy immunotherapies market, predict the report’s authors. Going forward, strategic alliances for the discovery of new drugs and immunotherapies are predicted to boost the market.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org